Please Wait
Applying Filters...

Finished Formulations with Xylitol Excipient

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ALLEGRA

02 1ALLEGRA ALLERGY

03 1ALLEGRA HIVES

04 3CHILDRENS ALLEGRA ALLERGY

05 3CHILDRENS ALLEGRA HIVES

06 1CHILDRENS FEXOFENADINE HYDROCHLORIDE ALLERGY

07 1CHILDRENS FEXOFENADINE HYDROCHLORIDE HIVES

08 1CLONAZEPAM

09 1ENALAPRIL MALEATE

10 1EXSERVAN

11 2GABAPENTIN

12 1MELOXICAM

13 1METFORMIN HYDROCHLORIDE

14 2MIRTAZAPINE

15 2NICORETTE

16 2NICORETTE (MINT)

17 13NICOTINE POLACRILEX

18 1OLANZAPINE

19 1OMEPRAZOLE AND SODIUM BICARBONATE

20 1ORENITRAM

21 1RIOMET

22 1RIOMET ER

23 1TOVIAZ

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

GABAPENTIN

Drug : GABAPENTIN

Dosage Form : SOLUTION; ORAL

Application Number : 78974

Country : US

Patented : No

Mission Pharmacal

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

OMEPRAZOLE; SODIUM BICARBONATE

Drug : OMEPRAZOLE AND SODIUM BICARBONATE

Dosage Form : FOR SUSPENSION; ORAL

Application Number : 79182

Country : US

Patented : No

Strides Pharma Science

04

AAPS 2024
Not Confirmed
arrow

07

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

CLONAZEPAM

Drug : CLONAZEPAM

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 77194

Country : US

Patented : No

blank

08

AAPS 2024
Not Confirmed
arrow